Most previous studies on ZBTB33 are related to cancer, but one study in mice related ZBTB33 to PGC-1a linked to hepatic inflammation and apoptosis, which indicates a potential role of ZBTB33 in NAFLD in humans and should be further investigated [26]. This evidence concerns the gene ZBTB33 and metabolic dysfunction-associated steatotic liver disease.